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1. Introduction 
Distarnycin A (D&/A) is an antiviral antibiotic 
which was shown to be active against several DNA 
viruses [l-3] and to inhibit the synthesis of adap- 
tive enzymes in bacteria [4]. Experimental studies 
suggest hat D&/A blocks some early steps in the 
growth cycle of DNA viruses, probably connected 
with DNA replication [S] . This mechanism correlates 
well with the ability of Dlst/A to bind to double- 
stranded and single-stranded DNA [6,7] and to in- 
hibit the template activity of DNA for DNA [8] and 
RNA [7] polymerases. 
The structure of Dist/A is characterized by 3 resi- 
dues of 1 -methyl-4-aminopyrrole-2-carboxylic acid 
and 2 side chains (fig. 1). Some structural analogues 
of Dist/A have been recently synthesized [9] by 
varying the number of pyrrole residues in the molecule. 
Chandra et al. [lo] have shown that the analogues 
containing 4 (Dist/4) and 5 (Distl5) pyrrole rings are 
more active than the parent compound on vaccinia 
virus and in the DNA-dependent RNA polymerase 
reaction. It is known that RNA-oncogenic viruses 
require DNA synthesis for their replication. This 
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prompted us to investigate the effect of Dist/A and 
its analogues on the murine sarcoma virus (MSV-M) 
in vitro. The antiviral activity of these analogues was 
found to be parallel to their extent of inhibition of 
DNA polymerase activity of RNA tumor viruses. 
2. Materials and methods 
3H-labeled deoxynucleoside triphosphates were 
obtained from NEN-Chemical GmbH, Germany. 
Unlabeled deoxynucleoside triphosphates were pur- 
chased from Nutritional Biochemicals Corp., Ohio, 
USA. Poly (dA-dT) and poly (A) were supplied by 
Miles Laboratories, Elkhart, Indiana, USA. Poly 
(dI-dC) was provided by Dr. G. Weimann of Boeh- 
ringer Mannheim GmbH, Tutzing. Oligo (dT)s was 
a kind gift of Dr. E. Lodemann, Frankfurt. The oligo- 
deoxy nucleotide (dT)s was annealed with poly (A) 
at 40” for 15 mln in a solution containing 200 /.Ig/ml 
of each component and allowing it to cool slowly 
at room temp. 
MSV-M, kindly supplied by Dr. J.B. Moloney 
(NCI, Bethesda, Md., USA) was passed by intramus- 
cular injection into suckling Swiss mice, and extracted 
from the tumor tissue. Friend leukemia virions (FLV) 
were isolated from infected spleens (AKR mice) and 
purified by sucrose-density gradient centrifugation. 
The viral extracts used to assay for DNA-polymerase 
activity were stored at -70” before use. 
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Fig. 1. Chemical structures of distamycin derivatives. 
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Fig. 2. Activity of distamycin derivatives on mouse embryo 
cells infected or not with MSV-M. ( -): Indicates inhibition 
of MSV-M foci formation; (- - - - ): inhibition of normal 
cell proliferation. On the abscissa: dose GM); on the ordinate: 
% of the corresponding control values. 
Antiviral activity assay: the experiments were 
carried out on mouse embryo fibroblast cultures, 
according to O’Connor [ 111. Cell cultures were in- 
fected with MSV at a multiplicity of infection of 
0.02 per cell, and treated with various drug concen- 
trations for 3 days after the virus adsorption. Foci 
were counted 5 days after the infection. 
Table 1 
Antivital and cytotoxic activities of some distamycin 
derivatives. 
Compound 
IDso 01M) 
Cell MSV 
TI 
Dist/A 32.0 12.6 2.5 
Dist/4 7.8 1.1 7.0 
Dist/S 3.4 0.44 7.7 
The activity of distamycin derivatives was tested on mouse 
embryo cells infected or not with MSV (M) as described 
under methods. IDso = Inhibiting dose 50%; TI = therapeutic 
index, ID50-cell/IDso-vims. 
DNA-polymerase assay: DNA-polymerase activity 
was assayed essentially by the method of Ross et al. 
[12]. The reaction mixture, regardless of template, 
was similar to that of Ross et al. [ 121, except hat 
we used 0.04 M Tris and the end concentration of 
Triton X-100 was 0.02%. The reaction mixture con- 
tained 0.2 pg of the template used. The reaction mix- 
tures containing virions (28 l.(g of protein) were in- 
cubated at 37’ for 90 min. Acid precipitable material 
was counted on “Millipore” filters (HAWP 02500) in 
a liquid scintillation counter. Protein was estimated by 
the method of Lowry et al. [ 131. 
Cytotoxic activity assay: uninfected cultures, 
treated parallel to the infected ones, were trypsinized 
5 days after the beginning of the experiment, and 
cells were counted in a hemocytometer. 
3. Results and discussion 
The results, reported in fig. 2, show that treatment 
,tith Dist/A, Dist/4 and Dist/S reduces the number of 
MSV-foci produced in vitro. The inhibitory activity 
was dependent on the dose used, and increased accord- 
ing to the number of pyrrole residues in the molecule. 
The cytotoxic activity of these compounds increases 
at higher doses; however, it was always less than their 
antiviral activity. 
Since the dose-dependent curves for cytotoxicity 
and antiviral activity are almost parallel, it was pos- 
sible to calculate the ratio cell-ID50/virus-ID50 (‘Ihera- 
peutic index = TI). As shown in table 1, the TI in- 
creased from 2.5 for Dist/A, to 7.0 for Dist/4 and to 
7.7 for Dist/S. These data confirm our previous ob- 
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Table 2 
Inhibition of reverse-transcriptas activity of FL-virions by distamycin derivatives in the absence of exogenous template. 
System Antibiotic used* 3H-TMP incorporation 
into DNA 
@pm/reaction mixt.) 
% of control 
Without vitions - 14 4.1 
Without Triton - 40 11.7 
Virions + RNase ** - 61 17.6 
Complete _ 343 100 
Complete D&/2 336 98 
Complete Dist/A 242 70.5 
Complete Dist/4 203 59 
Complete Dist/5 206 59.8 
* Antibiotic concentration = 20 pg/reaction mixt. 
** Virions containing Triton were prelncubated at room temp for 25 min with 50 pg/ml of pancreatic RNase. The reaction 
conditions are described under Materials and methods. 
Table 3 
Inhibition of DNA-polymerase activity of FL-virions by distamycin A and its analogues in the presence of various templates. 
Antibiotic used* 3H-TMP incorporation 
into DNA 
poly (dA-dT) 
(cpm/reaction mixt.)** 
3H-dGMP incorporation 
into DNA 
poly (dI-dC) 
(cpm/reaction mixt.)** 
3H-TMP incorporation 
into DNA 
~01~ rA- (dT)s 
@pm/reaction mixt.)** 
None 
Dist/Z 
D&/A 
Dist/4 
1020 (100) 506 (100) 520 (100) 
357 (35.8) 441 (87.5) 450 (85.5) 
137 (14) 442 (87.5) 330 (63.5) 
117 (11.9) 460 (91) 290 (55.5) 
* Antibiotic concentration =20 rg/reaction mixt. 
** The figures in brackets indicate percent of the control. The reaction conditions are described under Materials and methods. 
servations [lo] on the increase of antiviral activity 
(vaccinia virus) of Dist/4 and Dist/S, as compared 
with Dist/A, and show that this class of compounds 
is endowed with antiviral activity of MSV, an RNA- 
oncogenic virus whose replication depends on DNA 
synthesis. 
The existence of k-ion-associated DNA poly- 
merases [ 14, 151 in oncogenic RNA viruses suggests 
that information flow from RNA to DNA may be 
one of the reasons leading to oncogenesis. The search 
for specific inhibitors of this reaction has obvious im- 
plications in the chemotherapy of viral carcinogenesis. 
Synthetic polymers containing either deoxyribonu- 
cleotide or ribonucleoside strands can be used as 
template by the RNA-dependent DNA polymerase. 
The activity of distamycin derivatives on the DNA 
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polymerase activities of FLV and MSV-M using 
various templates was tested. 
As shown in table 2 the reverse transcriptase ac- 
tivity (without exogenous template) of FL-virions 
is inhibited by distamycin derivatives containing 
3,4 and 5 pyrrole rings. The compound containing 
2 pyrrole rings (Dist/2) is ineffective, which is 
similar to our observations on vaccinia virus, re- 
ported earlier [lo]. The compound with 4 pyrrole 
rings shows a higher inhibition than the one with 3 
pyrrole rings. This correlation could not be well de- 
monstrated with the compound containing 5 pyrrole 
rings. The compound Dist/S is very unstable and 
longer incubations (90 min) may cause some de- 
gradation of this compound. 
The inhibition of DNA polymerases of several on- 
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Table 4 
Inhibition of DNA polymerase activity of MSV (M) by distamycin A and its derivatives in the presence of 
various tempiates*. 
Antibiotic used** 3H-TMP incorporation 3H-dGMP incorporation 3H-TMP incorporation 
into DNA into DNA into DNA 
poly (dA-dT) poly (dI-dC) poly rA--(dT)a 
@pm/reaction mixt.) &pm/reaction mixt.) @pm/reaction mixt.) 
None 624 (100) 570 (100) 412 (100) 
Dist/Z 204 (32.6) 459 (86) 328 (80) 
Dist/A 144 (23) 441 (77) 280 (68.2) 
D&/s 60 (9.6) 447 (78) 214 (52) 
* The incorporation in the absence of templates was 157 cpm/reaction mixt. for ‘H-TMP, and 61 cpm/reaction mixt. for 
“H-dGMP. 
** Antibiotic concentration = 20 @g/reaction mixt..The figures in brackets indicate percent of the control. The reaction condi- 
tions are described under Materials and methods, 
cogenic viruses by ethidium bromide using various 
templates has been recently reported [ 161. This in- 
hibition was found to be dependent on the nature 
of the template used and the source of enzyme. It 
was therefore of interest to study the distamycin 
inhibition of DNA-polymerase activity in the pres- 
ence of various templates. 
The effect of distamycin derivatives on the DNA- 
polymerase activity of FLvirions in the presence 
of poly (dA-dT), poly (dI--dC) and poly rA-(dT)a 
is shown in table 3. With poly (dA-dT) as primer- 
template, the DNA-polymerase activity was found 
to be most sensitive to distamycin inhibition. The 
system containing poly rA-(dT)s is also very sensi- 
tive to distamycin inhibition, though the response 
in this case is weaker than that observed in the pres- 
ence of poly (dA-dT). It is important to note that 
in both cases the inhibitory response of the anti- 
biotic increases according to the number of pyrrole 
rings in the molecule. With poly (dI-dC) as template 
no significant inhibition of DNA-polymerase activity 
by distamycin derivatives was observed. 
Inhibition of DNA polymerase activity of MSV-M 
by distamycin A and its derivatives in the presence 
of various templates is shown in table 4. The DNA- 
polymerase activities catalyzed by poly (dA-dT) and 
poly rA-(dT)s are very sensitive to distamycin action. 
The range of inhibitions by individual derivatives is 
similar to that observed in FL-virions. However, the 
poly (dI-dC) de~ndent incorporation of dGMP by 
DNA polymerase was found to be more sensitive 
towards distamycins in this case. 
The experiments reported here demonstrate that 
the ~stamyc~ i~ibition of DNA polymerase acti- 
vities of FLV and MSV-M are template specific. Tem- 
plates containing thymine and adenine are highly 
sensitive to the action of distamycins. This ambition 
is dependent on the number of pyrrole rings in the 
molecule, also observed in the transcriptase reaction 
earlier [ 1 O] . The i~ibition of DNA polymerases of 
RNA oncogenic viruses and the foci formation by 
distamycin derivatives conclude that both activities 
are dependent on the same structural component(s) 
of the molecule. The in viva activity of distamycin de- 
rivatives on the oncogenic response of these viruses 
will be reported elsewhere. 
After this paper had been prepared for publication, 
we learned that Kotler and Becker 1171 had studied 
the activity of Dist/A and Dist/S on the reverse tran- 
scriptase activity of Rous sarcoma virions in the ab- 
sence of exogenous templates. Their data agree with 
our results on FL-virions reported in table 2. 
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